Polidocanol in a private practice for angiology and phlebology: A prospective and retrospective study of the results and complications of sclerotherapy;Sklerotherapie mit polidocanol in einer angiologisch-phlebologischen spezialpraxis: Prospektive und retrospektive erhebung über ergebnisse und komplikationen

Phlebologie

Volumn 32, Issue 3, 2003, Pages 76-80

  Breu, Franz Xaver ^a   Marshall, M ^a  

^a NONE

Author keywords

Polidocanol; Sclerotherapy

Indexed keywords

POLIDOCANOL;

ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LEG VARICOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHLEBITIS; RISK ASSESSMENT; SAPHENOUS VEIN; SCLEROTHERAPY; SKIN NECROSIS;

EID: 0038801680     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621445     Document Type: Article

References (22)

1. Arenander E, Lindhagen A. The evolution of varicose veins studied in a material of initially unilateral varices. VASA 1978; 7: 180.
2. Bihari I, Magyar EE. Microshunt histology in teleangiectasias. Int J Angiol 1999; 8: 98.
3. Bihari I, Magyar EE. Reasons for ulceration after injection treatment of teleangiectasia. Dermatol Surg 2001; 27: 133.
4. Breu FX, Marshall M. Verödungstherapie. In: Marshall M, Breu FX (Hrsg). Handbuch der Angiologie. 8. Ergänzungslieferung. Landsberg: Ecomed 2003.
5. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (aethoxysclerol) study. Phlebology 1994; 9: 17.
6. Duffy DM. Small vessel sclerotherapy: an overview. In Callen JP et al. (eds). Advances in dermatology. Vol. 3, Chicago: Mosby 1988.
7. Duffy DM. Cutaneous necrosis following sclerotherapy. J Aesthetic Dermatol Cosmetic Surg 1999; 1: 157.
8. Einarsson E, Eklöf B, Neglén P. Sclerotherapy or surgery as treatment for varicose veins: A prospective randomized study. Phlebology 1993; 8: 22.
9. Georgiev M. Postsclerotherapy hyperpigmentations: a one-year follow-up. J Dermatol Surg Oncol 1990; 16: 608.
10. Goldman MP. Sclerotherapy of superficial venules and teleangiectasias of the lower extremities. Dermatol Clin 1987; 5: 369.
11. Goldman MP. Polidocanol (aethoxysclerol) for sclerotherapy of superficial venules and teleangiectasias. J Dermatol Surg Oncol 1989; 15: 204.
12. Goldman MP, Bergan JJ. Sclerotherapy. Treatment of varicose and teleangiectatic leg veins. 3. ed. St. Louis, Missouri: Mosby 2001. Chapter 7. Meuchanism of action of sclerotherapy: 169; Chapter 8. Complications and adverse sequelae of sclerotherapy: 191.
13. Härtel SL. Fünf-Jahres-Nachuntersuchungsergebnisse der Sklerotherapie nach Stemmer bei 118 Patienten mit primärer Varikosis. Vasomed 1998; 4: 272.
14. Hübner K. Ambulante Therapie der Stammvarikose mittels Krossektomie und Sklerotherapie - ein Beitrag aus der Praxis des niedergelassenen Phlebologen. Phlebologie 1991; 20: 104.
15. Malouf GM. Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 2000; 59: 248.
16. Marmasse J. Enquete sur les embolies pulmonaires au cours du traitement sclerosant. Phlébologie 1964; 16: 175.
17. Natali J, Maraval M, Carrance F. Recent statistics on complications of sclerotherapy. Presented at the Annual Meeting of the North American Society of Phlebology, Maui, 1994, Feb 21.
18. Natali J, Farman T. Implications medico-legales au cours du traitement sclerosant des varices. J Mal Vasc (Paris) 1996; 21: 227.
19. , Norris MJ, Carlin MC, Ratz JL. Treatment of essential teleangiectasia: effects of increasing concentrations of polidocanol. J Am Acad Dermatol 1989; 20: 643.
20. Schadeck M. Echo-sclerotherapy. Phlébologie 1999; 52: 103.
21. Schultz-Ehrenburg U, Tourbier H. Doppler-kontrollierte Verödungsbehandlung der Vena saphena magna. Phlebol Proktol 1984; 13: 117.
22. Weiss RA, Sadick NS, Goldman MP, Weiss MA. Postsclerotherapy compression: Controlled comparative study of duration of compression and its effect on clinical outcome. Dermatol Surg 1999; 25: 105.